Enolase-1 is a therapeutic target in endometrial carcinoma
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
// Mengyang Zhao 1, 2, * , Weiyi Fang 1, 2, * , Yan Wang 2, 5, * , Suiqun Guo 6, * , Luyun Shu 6 , Lijing Wang 2, 6 , YiYu Chen 2 , Qiaofen Fu 2 , Yan Liu 2 , Shengni Hua 2 , Yue Fan 2 , Yiyi Liu 2 , Xiaojie Deng 2 , Rongcheng Luo 1 , Zhong Mei 5 , Qinping Jiang 2, 4 , Zhen Liu 2, 3 1 Cancer Center, Traditional Chinese Medicine-Integrated Hospital of Southern Medical University, Guangzhou, Guangdong, China 2 Cancer Research Institute, Southern Medical University, Guangzhou, China 3 Department of Pathology of Basic School, Medical University of Guangzhou, Guangzhou, China 4 Department of Pathology, Third Affiliated Hospital of Guangzhou Medical College, Guangzhou, China 5 Department of Obstetrics and Gynecology of Nanfang Hospital, Southern Medical University, Guangzhou, China 6 Department of Obstetrics and Gynecology, the Third Affiliated Hospital of Southern Medical University, Guangzhou, China * These authors have contributed equally to this work Correspondence to: Weiyi Fang, e-mail: fangweiyi1975@163.com Zhen Liu, e-mail: narcissus_jane@163.com Qingping Jiang, e-mail: 413430005@qq.com Keywords: ENO1, endometrial carcinoma, cell growth, EMT, glycolysis Received: December 30, 2014 Accepted: April 10, 2015 Published: April 24, 2015 ABSTRACT ENO1 plays a paradoxical role in driving the pathogenesis of tumors. However, the clinical significance of ENO1 expression remains unclear and its function and modulatory mechanisms have never been reported in endometrial carcinoma (EC). In this study, ENO1 silencing significantly reduced cell glycolysis, proliferation, migration, and invasion in vitro , as well as tumorigenesis and metastasis in vivo by modulating p85 suppression. This in turn mediated inactivation of PI3K/AKT signaling and its downstream signals including glycolysis, cell cycle progression, and epithelial-mesenchymal transition (EMT)-associated genes. These effects on glycolysis and cell growth were not observed after ENO1 suppression in normal human endometrial epithelial cells (HEEC). Knocking down ENO1 could significantly enhance the sensitivity of EC cells to cisplatin (DDP) and markedly inhibited the growth of EC xenografts in vivo . In clinical samples, EC tissues exhibited higher expression levels of ENO1 mRNA and protein compared with normal endometrium tissues. Patients with higher ENO1 expression had a markedly shorter overall survival than patients with low ENO1 expression. We conclude that ENO1 favors carcinogenesis, representing a potential target for gene-based therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zhou, B. P., Deng, J., Xia, W., Xu, J., Li, Y. M., Gunduz, M., & Hung, M.-C. (2004) · Nature Cell Biology · doi:10.1038/ncb1173 · Cited by 1,581 · cited 1×
“Snail is a key transcriptional factor that represses the expression of epithelial marker gene E-cadherin by binding to the E-Box site in its promoter [37] and induces the expression of mesenchymal marker N-cadherin [38] which stimulates cell migration, invasion, and metastasis in tumors.”
Backgroundc-Myc transactivation of LDH-A : Implications for tumor metabolism and growth
Shim, H., Dolde, C., Lewis, B. C., Wu, C.-S., Dang, G., Jungmann, R. A., Dalla-Favera, R., & Dang, C. V. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.13.6658 · Cited by 1,092 · cited 1×
“c-Myc has been shown to regulate LDHA at the transcriptional level [28] and could reprogram the core energy metabolism by regulating LDHA, leading to greater nutrient uptake and increased macromolecular biosynthesis [29–31].”
BackgroundMultiple Roles of the PI3K/PKB (Akt) Pathway in Cell Cycle Progression
Liang, J., & Slingerland, J. M. (2003) · Cell Cycle · doi:10.4161/cc.2.4.433 · Cited by 885
Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome
Reitman, Z. J., Jin, G., Karoly, E. D., Spasojevic, I., Yang, J., Kinzler, K. W., He, Y., Bigner, D. D., Vogelstein, B., & Yan, H. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019393108 · Cited by 449 · cited 1×
“Further sample preparation, metabolic profiling, peak identification and curation were performed by Metabolon (Durham, NC, USA) using their described methods [53].”
MethodCoordinated regulation of life and death by RB
Chau, B. N., & Wang, J. Y. J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc993 · Cited by 292 · cited 6×
“In this study, we firstly observed that ENO1 silencing significantly decreased the expression of c-Myc, p-Rb, E2F1, LDHA, Snail, and N-cadherin but upregulated P27Kip1 and E-cadherin expression (E-cadherin was not examined in HEC-1B cell line).”
BackgroundInfluentialThe role of c-myc in regulation of translation initiation
Schmidt, E. V. (2004) · Oncogene · doi:10.1038/sj.onc.1207548 · Cited by 166
Cited by
Cancer Vaccines, Adjuvants, and Delivery Systems
Paston, S. J., Brentville, V. A., Symonds, P., & Durrant, L. G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.627932 · Cited by 200
Zhan, P., Zhao, S., Yan, H., Yin, C., Xiao, Y., Wang, Y., Ni, R., Chen, W., Wei, G., & Zhang, P. (2017) · Molecular Carcinogenesis · doi:10.1002/mc.22603 · Cited by 75
Self-citationPost-translational modifications such as citrullination are excellent targets for cancer therapy
Brentville, V. A., Vankemmelbeke, M., Metheringham, R. L., & Durrant, L. G. (2020) · Seminars in Immunology · doi:10.1016/j.smim.2020.101393 · Cited by 53
Metadata
- Authors
- Zhao, M., Fang, W., Wang, Y., Guo, S., Shu, L., Wang, L., Chen, Y., Fu, Q., Liu, Y., Hua, S., Fan, Y., Liu, Y., Deng, X., Luo, R., Mei, Z., Jiang, Q., & Liu, Z.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2015-04-24
- Volume
- 6
- Issue
- 17
- Pages
- 15610-15627
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W1542899887
- Cited by
- 64
- References
- 6
- FWCI
- 2.45
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Enolase-1 is a therapeutic target in endometrial carcinoma. https://app.cochat.ai/papers/10.18632/oncotarget.3639
- The paper
- Zhao, M., Fang, W., Wang, Y., Guo, S., Shu, L., Wang, L., Chen, Y., Fu, Q., Liu, Y., Hua, S., Fan, Y., Liu, Y., Deng, X., Luo, R., Mei, Z., Jiang, Q., & Liu, Z. (2015). Enolase-1 is a therapeutic target in endometrial carcinoma. Oncotarget. https://doi.org/10.18632/oncotarget.3639
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.